Evidence map›Paper›PMID 33743659›Full record

Trial reportBMC women's health2021

Motivations to use hormonal contraceptive methods and condoms among HIV-positive and negative women randomized to a progestin contraceptive in Malawi: a qualitative study.

Agatha K Bula, Kendra Hatfield-Timajchy, John Chapola, L Chinula, Stacey A Hurst, Athena P Kourtis, J H Tang

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC women's health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Agatha K BulaUNC Project-Malawi, Private Bag A-104, Lilongwe, Malawi. abula@unclilongwe.org.ORCID 0000-0001-8440-7059
Kendra Hatfield-TimajchyU.S. Centers for Disease Control and Prevention, Atlanta, GA, USA.
John ChapolaUNC Project-Malawi, Private Bag A-104, Lilongwe, Malawi.
L ChinulaUNC Project-Malawi, Private Bag A-104, Lilongwe, Malawi.
Stacey A HurstU.S. Centers for Disease Control and Prevention, Atlanta, GA, USA.
Athena P KourtisU.S. Centers for Disease Control and Prevention, Atlanta, GA, USA.
J H TangDepartment of OB-GYN, University of North Carolina At Chapel Hill, Chapel Hill, NC, USA.
Centers for Disease Control and Prevention · USUniversity of Malawi · MWUniversity of North Carolina at Chapel Hill · US

Funding

Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
Evaluation of the immunologic and genital tract changes among Malawian women K01TW009657 · FIC · UNIV OF NORTH CAROLINA CHAPEL HILL · PI TANG, JENNIFER · 2013 to 2016
$565k
Bill and Melinda Gates Foundation OPP1090837CDC HHS 200-2015-M-63021CDC HHS U48DP001944FIC NIH HHS K01 TW009657NCCDPHP CDC HHS U48 DP001944NIAID NIH HHS P30 AI050410NIH HHS 1K01-TW009657-01USAID AID-OAA-A-15-00045
6 · The paper itself

Abstract

backgroundAlthough many countries have been promoting hormonal contraceptives to prevent unintended pregnancy and condom use to prevent HIV transmission, little is known about how women targeted by these messages have interpreted and internalized them. We describe HIV-positive and negative women's understanding of the benefits of contraception and condoms and their motivations to use them.

methodsThis is a qualitative sub-study from a clinical trial evaluating the effects of progestin contraception on HIV-positive and negative women aged 18-45 years randomly assigned to depot medroxyprogesterone acetate (DMPA) injection or levonorgestrel (LNG) implant. We purposively recruited 41 women to participate in in-depth interviews (IDIs) and focus group discussions (FGDs) after randomization into the main study. We conducted a total of 30 IDIs and 6 FGDs comprised of 4-7 women (N = 32). All women were counselled about potential risks for HIV acquisition/transmission with progestin-only contraception, drug-drug interactions between the implant and efavirenz-based ART, and the need to use condoms with their assigned contraceptive to help prevent pregnancy and HIV acquisition and transmission.

resultsAll women understood that HIV is transmitted through unprotected sex and that HIV transmission can be prevented through condom use but not DMPA injection or LNG implant use. Nearly all HIV-positive women knew or suspected that their partners were also HIV-positive and were most interested in using condoms to prevent infection with a drug-resistant HIV strain to keep their HIV viral load low. Almost all reported that their partners agreed to condom use, but few used them consistently. Most women believed that condoms were effective at preventing both HIV and pregnancy if used consistently. Nearly all women considered contraception and condom use as important in preventing unintended pregnancy and HIV because partner disclosure of HIV status is low.

conclusionOur results showed that both HIV-positive and negative women understood modes of HIV transmission and prevention and were aware that hormonal contraceptives are only effective for preventing pregnancy and not HIV. Although both HIV-negative and positive women were motivated to use condoms to prevent both HIV acquisition and infection with other HIV strains respectively, they all faced challenges from their partners in using condoms consistently.

Indexed as

CondomsHIV InfectionsContraceptionContraceptive AgentsFemaleHumansMalawiMotivationPregnancyProgestinsContraceptive AgentsProgestinsCondom useContraceptive useDepot medroxyprogesterone acetateLevonorgestrel implantMalawiMotivation

Identifiers

PMID33743659
PMCPMC7981805
OpenAlexW3137386759

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.